InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,555.58
(
-0.39%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Opti Mist

Send PM Follow Ignore
Followers 52
Posts 4107
Boards Moderated 0
Alias Born 07/03/2005

Opti Mist

Re: None

Friday, 01/12/2018 1:51:01 PM

Friday, January 12, 2018 1:51:01 PM

Post# of 4273
This is from back in December and set the choices facing SGYP and shareholders next week..

January May Determine The Fate Of Synergy Pharmaceuticals

Summary

January will be a critical month for Synergy.

The FDA will vote on indication expansion for Trulance and the company will have to prove that it has sufficient cash to qualify for the second tranche of a debt.

An expanded indication could prompt a buyout offer. Failure to set a clear course not involving further dilution could instigate a shareholder revolt.

Management has a lot to prove in January. External actors may soon get the scent of blood.

https://seekingalpha.com/article/4132529-january-may-determine-fate-synergy-pharmaceuticals?auth_param=38sjt:1d3fsd1:fc5d0b94a336992563d0aa23102eb237&uprof=45

Opti

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up